BioWorld

Sep. 9, 2002

When Finished, Human Genome Sequences Will Improve Disease Management, Geneticist Predicts

LION Cutting Back On Drugs To Focus On Support Systems

Other News To Note

Correction

Quarterly Earnings Reports

FDA Plan Could Lead To Faster Review Times For Biologics

The FDA intends to speed the review time of biologics by transferring the application process from the biologics center to the drug center. Read More

Employee Stock Options Remain An Issue For Congress, Regulators

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...